In This Article:
The big shareholder groups in Gufic Biosciences Limited (NSE:GUFICBIO) have power over the company. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones. I generally like to see some degree of insider ownership, even if only a little. As Nassim Nicholas Taleb said, 'Don’t tell me what you think, tell me what you have in your portfolio.
Gufic Biosciences is not a large company by global standards. It has a market capitalization of ₹5.6b, which means it wouldn't have the attention of many institutional investors. Our analysis of the ownership of the company, below, shows that institutional investors have bought into the company. We can zoom in on the different ownership groups, to learn more about GUFICBIO.
See our latest analysis for Gufic Biosciences
What Does The Institutional Ownership Tell Us About Gufic Biosciences?
Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.
Gufic Biosciences already has institutions on the share registry. Indeed, they own 10% of the company. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Gufic Biosciences, (below). Of course, keep in mind that there are other factors to consider, too.
Hedge funds don't have many shares in Gufic Biosciences. Our information suggests that there isn't any analyst coverage of the stock, so it is probably little known.
Insider Ownership Of Gufic Biosciences
The definition of company insiders can be subjective, and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.
I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.
Our information suggests that insiders maintain a significant holding in Gufic Biosciences Limited. It has a market capitalization of just ₹5.6b, and insiders have ₹2.3b worth of shares in their own names. This may suggest that the founders still own a lot of shares. You can click here to see if they have been buying or selling.